Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis

Background: In order to relieve the financial burden of the patients in China, the Ministry of Health (MoH) conducted the first national price negotiation and successfully negotiated three expensive medicines including 2 targeted anticancer medicines (TAMs), icotinib and gefitinib. However, little e...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Cong, Ung, Carolina Oi Lam, Wushouer, Haishaerjiang, Bai, Lin, Li, Xinyi, Guan, Xiaodong, Shi, Luwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808358/
https://www.ncbi.nlm.nih.gov/pubmed/34273922
http://dx.doi.org/10.34172/ijhpm.2021.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808358/
https://www.ncbi.nlm.nih.gov/pubmed/34273922
http://dx.doi.org/10.34172/ijhpm.2021.47

Ejemplares similares